Huipeng Li | Design of Materials and Components | Best Researcher Award
Dr. Huipeng Li | Hebei University of Technology | China
Dr. Huipeng Li is an Associate Professor at the School of Life Science and Health Engineering, Hebei University of Technology, whose research is centered on nanomedicine, biomaterials, immunotherapy, and regenerative medicine. He earned his B.S., M.S., and Ph.D. in Pharmaceutics from China Pharmaceutical University (2012, 2015, 2018) and began his career as an Assistant Researcher at Nanjing University (2018–2021), where he gained interdisciplinary expertise in drug delivery systems and biomimetic materials. Since joining Hebei University of Technology in 2022, and being promoted to Associate Professor in 2024, he has led several prestigious projects funded by the National Natural Science Foundation of China, the Ministry of Science and Technology, and Hebei Province. His research primarily focuses on precision treatment technologies and implantable material systems for degenerative diseases, artificial nano-bacteria as tumor and bacterial vaccines, personalized bionic skull repair materials, and nanovaccines for breast cancer immunotherapy. Dr. Li has published 6 academic papers, with 33 citations across 33 documents, and holds an h-index of 3, reflecting his growing scholarly influence. His work bridges pharmaceutics, nanotechnology, and biomedical engineering to address critical challenges in cancer therapy, infection prevention, and tissue regeneration. With high-impact projects and a clear vision of translating laboratory innovation into clinical solutions, Dr. Li continues to make significant contributions to the advancement of life science and health engineering.
Featured Publications
Yang, S., Li, S., Zhang, L., Zhao, M., Zhang, T., Liu, X., Liu, B., Zhang, H., Gong, Y., Zhou, H., Li, H., & Yang, L. (2025). A novel nanozyme-based coordination compound for synergistic periprosthetic joint infection treatment and bone repair. Advanced Healthcare Materials, 14, e02379.
Li, H., Yang, X., & Sun, M. (2024). Self-strengthened cascade-explosive nanogel using host–guest interaction strategy for synergistic tumor treatment. Chinese Chemical Letters, 35, 110651.
Chen, K., Li, H., Zhou, A., et al. (2022). Cell membrane camouflaged metal oxide–black phosphorus biomimetic nanocomplex enhances photo-chemo-dynamic ferroptosis. ACS Applied Materials & Interfaces, 14, xxx–xxx.
Chen, K., Li, H., Xu, Y., et al. (2022). Photoactive “bionic virus” robustly elicits the synergy anticancer activity of immunophotodynamic therapy. ACS Applied Materials & Interfaces, 14(3), 4456–4468.
Li, H., Yang, X., Gao, F., et al. (2018). Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy. Journal of Controlled Release, 285, xxx–xxx.
Li, H., Zhou, Z., Zhang, F., et al. (2018). A networked swellable dextrin nanogels loading Bcl2 siRNA for melanoma tumor therapy. Nano Research, 11, xxx–xxx.
Li, H., Yang, X., Zhou, Z., et al. (2017). Near-infrared light-triggered drug release from a multiple lipid carrier complex using an all-in-one strategy. Journal of Controlled Release, 261, 126–137.
Li, H., Wang, K., Yang, X., et al. (2017). Dual-function nanostructured lipid carriers to deliver IR780 for breast cancer treatment: Anti-metastatic and photothermal anti-tumor therapy. Acta Biomaterialia, 53, 399–413.